Print

Idera Pharmaceuticals, Inc. (IDRA) Reports Third Quarter 2013 Financial Results And Provides Corporate Update  
11/14/2013 9:28:04 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a clinical stage biopharmaceutical company developing a novel therapeutic approach for the treatment of autoimmune diseases and genetically defined forms of B-cell lymphoma, today reported financial results for the quarter ended September 30, 2013 and provided a corporate update.

Help employers find you! Check out all the jobs and post your resume.

//-->